These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 25531808)

  • 1. Assessment of acceptability and usability of new delivery prototype device for intradermal vaccination in healthy subjects.
    Van Mulder TJ; Verwulgen S; Beyers KC; Scheelen L; Elseviers MM; Van Damme P; Vankerckhoven V
    Hum Vaccin Immunother; 2014; 10(12):3746-53. PubMed ID: 25531808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunogenicity and safety of intradermal delivery of hepatitis B booster vaccine using the novel drug delivery device VAX-ID™.
    Van Mulder TJS; Withanage K; Beyers KCL; Vankerckhoven VVJ; Theeten H; Van Damme P
    Vaccine; 2019 Jan; 37(4):581-586. PubMed ID: 30587432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High frequency ultrasound to assess skin thickness in healthy adults.
    Van Mulder TJ; de Koeijer M; Theeten H; Willems D; Van Damme P; Demolder M; De Meyer G; Beyers KC; Vankerckhoven V
    Vaccine; 2017 Mar; 35(14):1810-1815. PubMed ID: 27496276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preclinical evaluation of performance, safety and usability of VAX-ID®, a novel intradermal injection device.
    Beyers KCL; Rbeihat MNM; S Vasconcelos D; Pasmans D; Verwulgen S; Vankerckhoven VVJ
    Vaccine; 2023 Jul; 41(31):4609-4615. PubMed ID: 37330370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the immunogenicity and safety of a split-virion, inactivated, trivalent influenza vaccine (Fluzone®) administered by intradermal and intramuscular route in healthy adults.
    Frenck RW; Belshe R; Brady RC; Winokur PL; Campbell JD; Treanor J; Hay CM; Dekker CL; Walter EB; Cate TR; Edwards KM; Hill H; Wolff M; Leduc T; Tornieporth N
    Vaccine; 2011 Aug; 29(34):5666-74. PubMed ID: 21699951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acceptability of fluzone intradermal vaccine to patients and vaccine administrators.
    Foy JE; Hendriksz T; Malouf P; Tobin A
    J Am Osteopath Assoc; 2013 Feb; 113(2):134-43. PubMed ID: 23412675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intradermal fractional booster dose of inactivated poliomyelitis vaccine with a jet injector in healthy adults.
    Soonawala D; Verdijk P; Wijmenga-Monsuur AJ; Boog CJ; Koedam P; Visser LG; Rots NY
    Vaccine; 2013 Aug; 31(36):3688-94. PubMed ID: 23770332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and immunogenicity of revaccination with reduced dose intradermal and standard dose intramuscular influenza vaccines in adults 18-64 years of age.
    Gorse GJ; Falsey AR; Johnson CM; Morrison D; Fried DL; Ervin JE; Greenberg DP; Ozol-Godfrey A; Landolfi V; Tsang PH
    Vaccine; 2013 Dec; 31(50):6034-40. PubMed ID: 24055306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Phase 1 clinical trial of a DNA vaccine for Venezuelan equine encephalitis delivered by intramuscular or intradermal electroporation.
    Hannaman D; Dupuy LC; Ellefsen B; Schmaljohn CS
    Vaccine; 2016 Jun; 34(31):3607-12. PubMed ID: 27206386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A dose-ranging study in older adults to compare the safety and immunogenicity profiles of MF59®-adjuvanted and non-adjuvanted seasonal influenza vaccines following intradermal and intramuscular administration.
    Della Cioppa G; Nicolay U; Lindert K; Leroux-Roels G; Clement F; Castellino F; Galli C; Groth N; Levin Y; Del Giudice G
    Hum Vaccin Immunother; 2014; 10(6):1701-10. PubMed ID: 24732325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intradermally-administered influenza virus vaccine is safe and immunogenic in healthy adults 18-64 years of age.
    Gorse GJ; Falsey AR; Fling JA; Poling TL; Strout CB; Tsang PH
    Vaccine; 2013 May; 31(19):2358-65. PubMed ID: 23499604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Topical imiquimod before intradermal trivalent influenza vaccine for protection against heterologous non-vaccine and antigenically drifted viruses: a single-centre, double-blind, randomised, controlled phase 2b/3 trial.
    Hung IF; Zhang AJ; To KK; Chan JF; Li P; Wong TL; Zhang R; Chan TC; Chan BC; Wai HH; Chan LW; Fong HP; Hui RK; Kong KL; Leung AC; Ngan AH; Tsang LW; Yeung AP; Yiu GC; Yung W; Lau JY; Chen H; Chan KH; Yuen KY
    Lancet Infect Dis; 2016 Feb; 16(2):209-18. PubMed ID: 26559482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intramuscular vs intradermal route for hepatitis B booster vaccine in celiac children.
    Leonardi S; Praticò AD; Lionetti E; Spina M; Vitaliti G; La Rosa M
    World J Gastroenterol; 2012 Oct; 18(40):5729-33. PubMed ID: 23155313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of higher-dose intradermal hepatitis B vaccination to standard intramuscular vaccination of healthcare workers.
    Henderson EA; Louie TJ; Ramotar K; Ledgerwood D; Hope KM; Kennedy A
    Infect Control Hosp Epidemiol; 2000 Apr; 21(4):264-9. PubMed ID: 10782589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunogenicity and safety of intradermal influenza vaccination in healthy older adults.
    Chi RC; Rock MT; Neuzil KM
    Clin Infect Dis; 2010 May; 50(10):1331-8. PubMed ID: 20377407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A single center, open label study of intradermal administration of an inactivated purified chick embryo cell culture rabies virus vaccine in adults.
    Recuenco S; Warnock E; Osinubi MOV; Rupprecht CE
    Vaccine; 2017 Aug; 35(34):4315-4320. PubMed ID: 28688782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and efficacy of a novel microneedle device for dose sparing intradermal influenza vaccination in healthy adults.
    Van Damme P; Oosterhuis-Kafeja F; Van der Wielen M; Almagor Y; Sharon O; Levin Y
    Vaccine; 2009 Jan; 27(3):454-9. PubMed ID: 19022318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acceptability of Intanza® 15 μg intradermal influenza vaccine in Belgium during the 2010-2011 influenza season.
    Dhont PA; Albert A; Brenders P; Podwapinska A; Pollet A; Scheveneels D; Tihon F; Verheyden I; Victor J; Samson SI
    Adv Ther; 2012 Jun; 29(6):562-77. PubMed ID: 22678831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety, tolerability and efficacy of intradermal rabies immunization with DebioJect™.
    Vescovo P; Rettby N; Ramaniraka N; Liberman J; Hart K; Cachemaille A; Piveteau LD; Zanoni R; Bart PA; Pantaleo G
    Vaccine; 2017 Mar; 35(14):1782-1788. PubMed ID: 28317660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Performance and usability evaluation of novel intradermal injection device Immucise™ and reanalysis of intradermal administration trials of influenza vaccine for the elderly.
    Shimizu S; Tanaka R; Itoh E; Maekawa-Matsuura M; Iwase Y
    Vaccine; 2022 Feb; 40(6):873-879. PubMed ID: 35031147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.